Jing Zhang

Prof. Jing Zhang


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2025 in Frontiers in Psychiatry
Verified
Journal Article
Open access
PDF file
KGKeying Guo
Keying Guo
HLHaipeng Li
Haipeng Li
WDWeina Du
Weina Du
LCLing Cheng
Ling Cheng
WWWei Wang
Wei Wang
JZJing Zhang
Jing Zhang
Purpose: The primary aim of this study is to explore distinct patterns of post-traumatic growth (PTG) and fear of cancer progression (FOP) among breast cancer patients through latent profile analysis (LPA). Additionally, we assessed the differences in demographic and disease-related factors among breast cancer patients with varying patterns. Finally, we examined the influence of socio-demographic, disease-related, social support, anxiety, depression, and post-traumatic stress disorder (PTSD) factors on the varying patterns, aiming to assist healthcare providers in developing more effective psychological care strategies for breast cancer patients.Method: A questionnaire survey was conducted on 752 breast cancer patients. Latent profile analysis was employed to explore the patterns of post-traumatic growth and fear of cancer progression in these patients, and multiple logistic regression analysis was used to identify the predictive factors for the different patterns.Results: Based on the fit indices of latent class analysis, a three-class model was identified as the optimal solution, which included the Resisting group, Struggling group, and Growth group. In the Resisting group (24.33%), patients reported low levels of post-traumatic growth and high levels of fear of cancer progression; in the Struggling group (46.14%), patients exhibited moderate levels of post-traumatic growth and low levels of fear of cancer progression; in the Growth group (29.52%), patients demonstrated high levels of post-traumatic growth and moderate levels of fear of cancer progression. Additionally, the multiple logistic regression analysis reveals that marital status, place of residence, education level, disease stage, social support, anxiety, and post-traumatic stress disorder levels in breast cancer patients serve as significant factors influencing the distinct patterns of post-traumatic growth and fear of progression.Conclusions: This study suggests that there is heterogeneity in the PTG and FOP patterns in breast cancer patients. It provides a research basis for promoting the psychological recovery of breast cancer patients and highlights the importance of focusing on the positive effects of PTG while mitigating the negative impact of FOP. Healthcare providers can implement targeted nursing interventions based on the different patterns observed in breast cancer patients.

19 February 2025 in Frontiers in Public Health
Verified
Journal Article
Open access
PDF file
FXFang Xue
Fang Xue
JLJing Liu
Jing Liu
TZTong Zhou
Tong Zhou
XLXiuchuan Li
Xiuchuan Li
CLChunfang Liu
Chunfang Liu
JZJing Zhang
Jing Zhang
Objective: To investigate burnout, sense of coherence (SOC), and job safety attitudes among nurses in China after the coronavirus disease 2019 (COVID-19) pandemic.Methods: This cross-sectional study included 302 front-line nurses from Fangcang shelter hospitals (FSHs) in China. Descriptive, univariate, Pearson’s correlation, and multiple linear regression analyses were conducted to analyze factors related to job safety attitudes of nurses toward FSHs.Results: The incidence of burnout among nurses in FSHs was 65.2%; 57.9% had a low level of SOC, the score for safety attitude was 74.47 (standard deviation = 13.33), and the agreement rate was 51%. Burnout was negatively correlated with SOC (r = −0.399, p < 0.01) and safety attitudes (r = −0.141, p < 0.05), and SOC was positively correlated with safety attitudes (r = 0.428, p < 0.01). Personal accomplishment, depersonalization, changes in working hours, manageability, and marital status explained 33.8% of the variance in work safety attitudes.Conclusion: This study investigated the levels of burnout, SOC, and safety attitudes among nurses after COVID-19 in Chinese FSHs for the first time, and analyzed the associated factors. The results are valuable for improving the quality of nursing safety as well as patient safety management in FSHs.

15 March 2025 in iScience
Verified
Journal Article
Open access
FXFang Xue
Fang Xue
JLJing Liu
Jing Liu
JWJinyan Wu
Jinyan Wu
XLXueer Li
Xueer Li
NZNingning Zhu
Ningning Zhu
JZJing Zhang
Jing Zhang
Alisertib is a potent aurora A kinase inhibitor in clinical trials for cancer treatment, but its efficacy on cancer vaccines remains unclear. Here, we developed a DNA vaccine targeting glypican-3 (pGPC3) and evaluated its efficacy with alisertib in hepatocellular carcinoma (HCC) models. The combination therapy of pGPC3 vaccine and alisertib significantly inhibited subcutaneous tumor growth, enhanced the induction and maturation of CD11c+ and CD8+CD11c+ dendritic cells (DCs), and expanded tumor-specific CD8+ T cell responses. CD8+ T cell depletion abolished the anti-tumor effects, underscoring the essential role of functional CD8+ T cell responses. Moreover, the combined treatment promoted memory CD8+ T cell induction, providing long-term protection. In liver orthotopic tumor models, the combination of pGPC3 vaccine and alisertib demonstrated potent therapeutic efficacy through CD8+ T cell responses. These results indicate that alisertib enhances the pGPC3 vaccine's therapeutic effect, offering a promising strategy for HCC treatment.

1 April 2025 in Journal of Multidisciplinary Healthcare
Verified
Journal Article
Open access
PDF file
XWXiaoyu Wei
Xiaoyu Wei
PYPing Ye
Ping Ye
LCLingling Chen
Lingling Chen
HTHuiqin Tang
Huiqin Tang
WYWeiwei Yin
Weiwei Yin
JZJing Zhang
Jing Zhang
Purpose: To comprehensively assess the knowledge, attitudes, and practices (KAP) of Chinese breast cancer (BC) patients regarding postoperative self-management (POSM) and identify factors influencing self-management behaviors. Methods: Questionnaire surveys were administered to BC patients who underwent surgery. A total of 566 participants (98.94% female), mainly from rural areas (65.55%) and married (97.53%), were included. Knowledge was measured using 10 questions (score range: 0– 20), attitude with 6 questions (score range: 6– 30), and practice with 7 questions (score range: 6– 30). Scores were categorized as inadequate (0%– 39.99%), moderate (40%– 70%), or satisfactory (> 70% of maximum score). Demographic data were collected, and statistical analyses, including T-tests, ANOVA, non-parametric tests, and Spearman correlation, were used for comparisons and associations. Results: The average knowledge score was 20.00 (100% of the maximum score), with correct answer rates ranging from 92.58% to 99.29%. Attitude scores averaged 29.00 (96.66% of maximum), with 95.93– 98.76% of participants showing positive or very positive attitudes. The average practice score was 26.00 (86.66% of maximum), with notable gaps in seeking psychological support (28.27% negative responses) and lifestyle adjustments (41.34% negative responses). Pearson correlation analysis revealed positive associations between knowledge and attitude (r = 0.227, p < 0.001), and attitude and practice (r = 0.111, p = 0.008). Multivariable analysis found homemakers showed better practices compared to employed individuals (OR = 9.667, 95% CI = 2.483– 37.643, p = 0.001), while those with “other” employment status had lower odds of practice (OR = 0.437, 95% CI = 0.206– 0.927, p = 0.031). Patients with Stage II or III tumors had lower odds of practice compared to Stage I tumors (OR = 0.273, 95% CI = 0.110– 0.677, p = 0.005; OR = 0.157, 95% CI = 0.060– 0.410, p < 0.001, respectively). Conclusion: This study highlights the importance of addressing gaps between knowledge, attitudes, and practices in BC patients undergoing postoperative recovery. Tailored interventions focusing on specific barriers identified in practice behaviors, such as seeking psychological support and lifestyle adjustments, are crucial to enhance overall postoperative care and improve health outcomes for BC patients.

15 April 2026 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
PDF file
HLHaipeng Li
Haipeng Li
JYJiaqi Yan
Jiaqi Yan
YLYuxi Liu
Yuxi Liu
XTXunqian Tao
Xunqian Tao
KGKeying Guo
Keying Guo
JZJing Zhang
Jing Zhang
Chimeric antigen receptor T (CAR-T) cell therapy has achieved transformative success in hematological malignancies; however, its translation to solid tumors remains severely limited by tumor heterogeneity, immunosuppressive microenvironments, and safety concerns such as on-target/off-tumor toxicity. A major contributor to these challenges is the lack of preclinical models capable of faithfully recapitulating human tumor architecture and tumor-immune interactions. Conventional two-dimensional cell cultures and animal models frequently fail to predict CAR-T efficacy, resistance, and toxicity observed in patients. Organoid technology, particularly patient-derived organoids (PDOs) and immune-integrated organoid systems, has emerged as a next-generation platform that bridges this translational gap. By preserving patient-specific genetic, phenotypic, and spatial heterogeneity, organoids provide a physiologically relevant and scalable system for interrogating CAR-T cell behavior in human-like tumor contexts. Recent advances in tumor-immune co-culture, vascularized organoids, and microfluidic organoid-on-a-chip platforms have further expanded their utility for dynamic assessment of CAR-T infiltration, cytotoxicity, cytokine release, and adaptive resistance mechanisms. In this review, we comprehensively examine how organoid-based models are reshaping the CAR-T development pipeline, spanning target discovery and validation, functional efficacy assessment, safety profiling, and optimization of combination therapies. We further discuss emerging applications of organoids as patient-specific “avatars” for personalized CAR-T selection and response prediction. Finally, we highlight current technical limitations and future bioengineering directions required to enable clinical translation. Collectively, organoid platforms represent a transformative tool for accelerating precision development of next-generation CAR-T cell therapies and advancing human-relevant immuno-oncology research.

28 January 2026 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
WWWei Wang
Wei Wang
KGKeying Guo
Keying Guo
WDWeina Du
Weina Du
LCLing Cheng
Ling Cheng
HGHe Gao
He Gao
JZJing Zhang
Jing Zhang
Objectives: This study investigates factors influencing benefit finding among breast cancer patients based on social cognitive theory and develops a nomogram to predict the probability of low benefit finding in breast cancer patients. Methods: A study of 666 breast cancer patients in northern Anhui Province (January to December 2024) employed latent profile analysis to identify distinct benefit finding patterns. Potential predictors were identified through univariate analysis, least absolute shrinkage and selection operator regression, and multivariate analysis. Five machine learning algorithms were applied to predict low benefit finding, with performance evaluated via calibration and discriminative power metrics and internally validated using bootstrap resampling. Results: A two-classification model best fits the data, identifying the low benefit finding category (35%) and the high benefit finding category (65%). XGBoost outperformed other models and was selected as the final model. The model achieved an AUC of 0.945 on the validation set. SHAP analysis quantified each variable’s contribution to predictions, revealing age, medication adherence, anxiety, social support, and depression as key determinants of benefit finding. Conclusion: This study applied social cognitive theory to examine factors affecting benefit finding in breast cancer patients, focusing on environmental, individual, and behavioral domains. Results showed strong performance by the XGBoost classifier. The developed nomogram aids healthcare providers in swiftly identifying patients with low benefit finding, enabling personalized interventions to mitigate adverse psychological effects and improve long-term outcomes.